Cargando…

Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults

BACKGROUND: Obesity exacerbates age-related decline in glucometabolic control. Undercarboxylated osteocalcin (UcOC) regulates pancreatic insulin secretion. The long-term effect of lifestyle interventions on UcOC and insulin secretion has not been investigated. METHODS: One hundred seven frail, obese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colleluori, Georgia, Napoli, Nicola, Phadnis, Uma, Armamento-Villareal, Reina, Villareal, Dennis T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603129/ https://www.ncbi.nlm.nih.gov/pubmed/28951766 http://dx.doi.org/10.1155/2017/4807046

Ejemplares similares

Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial
por: Bouchonville, Matthew, et al.
Publicado: (2013)

Undercarboxylated osteocalcin correlates with insulin secretion in Japanese individuals with diabetes
por: Funakoshi, Shogo, et al.
Publicado: (2020)

Fat Mass Follows a U-Shaped Distribution Based on Estradiol Levels in Postmenopausal Women
por: Colleluori, Georgia, et al.
Publicado: (2018)

Adipocytes ESR1 Expression, Body Fat and Response to Testosterone Therapy in Hypogonadal Men Vary According to Estradiol Levels
por: Colleluori, Georgia, et al.
Publicado: (2018)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2017)

MON-382 Bone Quality and Strength in Obese Men with Type 2 Diabetes Mellitus Are Impaired and Negatively Influenced by Adiposity
por: Vigevano, Francesca, et al.
Publicado: (2020)

Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects
por: Colleluori, Georgia, et al.
Publicado: (2020)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
por: Deepika, FNU, et al.
Publicado: (2022)

Fat, Muscle, and Bone Interactions in Obesity and the Metabolic Syndrome
por: Armamento-Villareal, Reina, et al.
Publicado: (2014)

Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults
por: Aguirre, Lina E., et al.
Publicado: (2014)

OR27-01 Upregulated Prdm16 Impairs Adipogenesis And Promotes Myogenesis Via PAX7 And Osteogenesis In Testosterone-treated Hypogonadal Men
por: Bathina, Siresha, et al.
Publicado: (2023)

Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal Women
por: Atalay, Sacide, et al.
Publicado: (2012)

OR25-6 In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dL is Associated with Greater Improvement in Body Composition, While Level of ≥264 ng/dL Favors Improvement in Metabolic Profile
por: Aguirre, Lina, et al.
Publicado: (2022)

Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism
por: Harslof, Torben, et al.
Publicado: (2016)

Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes
por: Razny, Urszula, et al.
Publicado: (2016)

Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity
por: Lin, Xuzhu, et al.
Publicado: (2018)

Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a
por: Wang, Hailong, et al.
Publicado: (2021)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

Undercarboxylated osteocalcin reverts insulin resistance induced by endoplasmic reticulum stress in human umbilical vein endothelial cells
por: Guo, Qinyue, et al.
Publicado: (2017)

SUN-LB69 A Comparison Between Weight Loss Associated Bone Loss From Lifestyle Measures Versus Bariatric Surgery
por: La, Betty, et al.
Publicado: (2020)

A Single Dose of Prednisolone as a Modulator of Undercarboxylated Osteocalcin and Insulin Sensitivity Post-Exercise in Healthy Young Men: A Study Protocol
por: Levinger, Itamar, et al.
Publicado: (2016)

Diversity of Gut Microbiota Affecting Serum Level of Undercarboxylated Osteocalcin in Patients with Crohn’s Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2019)

Undercarboxylated, But Not Carboxylated, Osteocalcin Suppresses TNF-α–Induced Inflammatory Signaling Pathway in Myoblasts
por: Park, Danbi, et al.
Publicado: (2022)

Bone Turnover Markers Including Undercarboxylated Osteocalcin Are Associated With Mortality Risk in Older Men
por: Robertson, Courtney L, et al.
Publicado: (2022)

Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women
por: Zanatta, Leila C. B., et al.
Publicado: (2018)

Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa, et al.
Publicado: (2021)

Association between Osteocalcin, Metabolic Syndrome, and Cardiovascular Risk Factors: Role of Total and Undercarboxylated Osteocalcin in Patients with Type 2 Diabetes
por: Alfadda, Assim A., et al.
Publicado: (2013)

Relationship between serum osteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol
por: Liu, Yihui, et al.
Publicado: (2019)

Indices of sarcopenic obesity are important predictors of finite element analysis-derived bone strength in older adults with obesity
por: Gregori, Giulia, et al.
Publicado: (2023)

Correction: Relationship between serum osteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol
Publicado: (2019)

Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review
por: Russo, Vittoria, et al.
Publicado: (2021)

Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review
por: Deepika, Fnu, et al.
Publicado: (2023)

Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
por: Mori, Katsuhito, et al.
Publicado: (2012)

Correlation of Undercarboxylated Osteocalcin (ucOC) Concentration and Bone Density with Age in Healthy Korean Women
por: Kim, Sang-Man, et al.
Publicado: (2010)

Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease
por: Zhang, Minfang, et al.
Publicado: (2015)

Circulating Undercarboxylated Osteocalcin as Estimator of Cardiovascular and Type 2 Diabetes Risk in Metabolic Syndrome Patients
por: Riquelme-Gallego, Blanca, et al.
Publicado: (2020)

Undercarboxylated osteocalcin has no adverse effect on endothelial function in rabbit aorta or human vascular cells
por: Tacey, Alexander, et al.
Publicado: (2020)

Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment
por: Gu, Peng-Ying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_reemoi8umqc98sv18quu44uk4i